 compar efficaci toxic second-lin drug rheumatoid arthriti result metaanalys metaanalys placebo-control compar clinic trial rel efficaci toxic methotrex mtx inject gold d-penicillamin DP sulfasalazin ssz aur antimalari drug second-lin drug rheumatoid arthriti RA efficaci studi set inclus criteria trial inform tender joint count erythrocyt sediment rate grip strength clinic trial treatment group interest drug treatment group outcom result aur second-lin drug result outcom measur composit measur outcom aur mtx inject gold DP ssz antimalari agent heterogen antimalari agent patient chloroquin hydroxychloroquin littl differ efficaci mtx inject gold DP ssz power analysi trial patient treatment group effect effect aur second-lin drug none interdrug compar trial larg toxic studi inclus criteria RA trial proport patient therapi drug toxic total proport clinic trial treatment group averag proport averag proport drug toxic drug overal patient trial drug toxic inject gold toxic rate total dropout rate drug gold-treat patient side effect trial patient antimalari drug aur low rate toxic rate mtx discrep trial thu commonli second-lin drug aur inject gold toxic agent futur drug abstract truncat AT word